Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China
· Delayed Price · Currency is CNY 6.03
+0.04 (0.67%)
May 13, 2025, 2:45 PM CST
SHE:002550 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 412.89 | 356.03 | 181.86 | 323.41 | 181.08 | -132.02 | Upgrade
|
| Depreciation & Amortization | 64.61 | 64.61 | 69.22 | 64.76 | 69.43 | 70.25 | Upgrade
|
| Other Amortization | 5.27 | 5.27 | 3.75 | 3.55 | 5.67 | 3.39 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -25.35 | -57.59 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.04 | 0.04 | 7.77 | 0.24 | 0.46 | 1.6 | Upgrade
|
| Loss (Gain) From Sale of Investments | -13.89 | -13.89 | -8.83 | 3.82 | -0.64 | -16.03 | Upgrade
|
| Provision & Write-off of Bad Debts | 6.04 | 6.04 | -19.02 | 15.3 | -52.68 | 5.04 | Upgrade
|
| Other Operating Activities | -257.94 | -101.48 | 19.11 | -46.62 | 6.11 | 390.89 | Upgrade
|
| Change in Accounts Receivable | -12.26 | -12.26 | 420.4 | -165.9 | 55.37 | 49.78 | Upgrade
|
| Change in Inventory | 172.11 | 172.11 | -77.46 | -136.12 | -84.79 | -73.03 | Upgrade
|
| Change in Accounts Payable | 24.09 | 24.09 | -50.63 | -83.14 | -86.65 | 82.57 | Upgrade
|
| Change in Other Net Operating Assets | -0.62 | -0.62 | 1.98 | 4.37 | 4.12 | 4.07 | Upgrade
|
| Operating Cash Flow | 415.11 | 514.71 | 533.33 | -71.47 | 103.56 | 317.28 | Upgrade
|
| Operating Cash Flow Growth | -43.33% | -3.49% | - | - | -67.36% | 96.40% | Upgrade
|
| Capital Expenditures | -103.72 | -90.64 | -100.33 | -70.99 | -90.37 | -62.53 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 13.5 | 32.3 | 0.11 | 0 | 0.02 | Upgrade
|
| Cash Acquisitions | - | - | - | -1.67 | - | - | Upgrade
|
| Investment in Securities | -232.15 | -232.15 | -108.5 | -121.08 | 177.22 | 489.88 | Upgrade
|
| Other Investing Activities | 59.54 | -13.94 | 1.43 | 3.65 | 8.43 | 32.17 | Upgrade
|
| Investing Cash Flow | -276.33 | -323.23 | -175.1 | -189.98 | 95.28 | 459.53 | Upgrade
|
| Short-Term Debt Issued | - | 4.69 | 435.51 | 461.27 | 124.95 | 326.15 | Upgrade
|
| Total Debt Issued | 4.69 | 4.69 | 435.51 | 461.27 | 124.95 | 326.15 | Upgrade
|
| Short-Term Debt Repaid | - | -40.1 | -480 | -440 | -77.43 | -628.54 | Upgrade
|
| Total Debt Repaid | -40.1 | -40.1 | -480 | -440 | -77.43 | -628.54 | Upgrade
|
| Net Debt Issued (Repaid) | -35.41 | -35.41 | -44.49 | 21.27 | 47.52 | -302.39 | Upgrade
|
| Issuance of Common Stock | - | - | - | 144.9 | - | 171.84 | Upgrade
|
| Repurchase of Common Stock | -140.77 | -140.77 | -30.09 | - | -0.19 | -0.3 | Upgrade
|
| Common Dividends Paid | -152 | -151.52 | -158.79 | -155.16 | -151.51 | -313.62 | Upgrade
|
| Other Financing Activities | 143.77 | 3 | 42.5 | - | - | - | Upgrade
|
| Financing Cash Flow | -184.41 | -324.71 | -190.87 | 11.02 | -104.17 | -444.47 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.07 | -1.85 | -1.6 | 41.89 | 7.39 | -18.6 | Upgrade
|
| Net Cash Flow | -45.7 | -135.07 | 165.76 | -208.55 | 102.06 | 313.74 | Upgrade
|
| Free Cash Flow | 311.39 | 424.07 | 433 | -142.46 | 13.19 | 254.74 | Upgrade
|
| Free Cash Flow Growth | -51.20% | -2.06% | - | - | -94.82% | 318.51% | Upgrade
|
| Free Cash Flow Margin | 20.54% | 27.79% | 23.87% | -6.18% | 0.70% | 15.28% | Upgrade
|
| Free Cash Flow Per Share | 0.24 | 0.33 | 0.33 | -0.11 | 0.01 | 0.21 | Upgrade
|
| Cash Income Tax Paid | 153.02 | 150.65 | 45.16 | 26.55 | 81.87 | 79.15 | Upgrade
|
| Levered Free Cash Flow | -14.44 | 334.4 | 344.34 | -216.74 | -40.56 | 609.25 | Upgrade
|
| Unlevered Free Cash Flow | -13.57 | 335.27 | 348.04 | -213.46 | -39.53 | 614.53 | Upgrade
|
| Change in Net Working Capital | 163.51 | -178.19 | -272.06 | 354.27 | 123.62 | -468.1 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.